ToxSci Advance Access published online on December 7, 2005
Toxicological Sciences, doi:10.1093/toxsci/kfj067
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pharmaceutical Reserch Center, Mochida Pharmaceutical Company Limited, Shizuoka, Japan
* To whom correspondence should be addressed. Excessive accumulation of phospholipids results in phospholipidosis (PL) which may interfere with cellular functions, leading to acute or chronic disease, or even death. Electron-microscopic detection of cytoplasmic lamellar bodies is often used as a diagnostic criterion of PL, but a faster, more convenient procedure is required for high-throughput assay of the PL-inducing potential of candidate drugs. We have developed a 96-well microplate cell-culture method for detecting PL, using a phosphatidylcholine-conjugated dye (NBD-PC) and a fluoro-microplate reader. The fluorescence intensity due to NBD-PC was normalized to that of Hoechst33342, used as an indicator of cell number, to obtain the amount of NBD-PC taken up per living cell. To select a suitable cell type, we examined the PL-detection sensitivity of 5 cell lines, as well as human and rat primary hepatocyte cultures, with five cationic amphiphilic drugs (CAD) as PL inducers and a negative control compound. The cell lines CHO-K1 and CHL/IU gave the best results. The NBD-PC uptake per CHO-K1 cell showed a high correlation with the pathological score of PL for 24 compounds, including PL-positive and negative compounds. This high-throughput screening assay for PL-inducing potential (HTS-PL assay) offers high sensitivity and accuracy, and allows simultaneous determination of cytotoxicity.
Received August 29, 2005
Accepted November 16, 2005
In Vitro Toxicology
Establishment of an In Vitro High-Throughput Screening Assay for Detecting Phospholipidosis-Inducing Potential
Toshihiko Kasahara 1 *,
Kazuo Tomita 1,
Hiroyuki Murano 2,
Tsuyoshi Harada 3,
Keisuke Tsubakimoto 1,
Takuo Ogihara 1,
Syuhei Ohnishi 1,
and
Chihaya Kakinuma 1
2 Research Planning and Management, Mochida Pharmaceutical Company Limited, Shizuoka, Japan
3 Development Research, Mochida Pharmaceutical Company Limited, Shizuoka, Japan
Toshihiko Kasahara, E-mail: kasat{at}mochida.co.jp
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Nioi, B. K. Perry, E.-J. Wang, Y.-Z. Gu, and R. D. Snyder In Vitro Detection of Drug-Induced Phospholipidosis Using Gene Expression and Fluorescent Phospholipid Based Methodologies Toxicol. Sci., September 1, 2007; 99(1): 162 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Atienzar, H. Gerets, S. Dufrane, K. Tilmant, M. Cornet, S. Dhalluin, B. Ruty, G. Rose, and M. Canning Determination of Phospholipidosis Potential Based on Gene Expression Analysis in HepG2 Cells Toxicol. Sci., March 1, 2007; 96(1): 101 - 114. [Abstract] [Full Text] [PDF] |
||||
